# HEMAB THERAPEUTICS HLDGS INC COM SHS

HEMAB THERAPEUTICS HLDGS INC COM SHS is a security (CUSIP 423494103) tracked across SEC portfolio filings. 5 institutional managers reported $3.3M on Form 13F as of 2026-06-30; 2 registered fund positions totaling $15.2M via N-PORT as of 2026-05-31.

## Summary

- Issuer: HEMAB THERAPEUTICS HLDGS INC
- Class: COM SHS
- CUSIP: 423494103
- Asset category: EC
- 13F holders: 5
- 13F value: $3.3M
- 13F period: 2026-06-30
- N-PORT fund positions: 2
- N-PORT value: $15.2M
- N-PORT report: 2026-05-31

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| Aberdeen Group plc | EDINBURGH, X0 | $1.9M | 52,117 |
| TD Asset Management Inc | Toronto, A6 | $1.2M | 33,098 |
| China Universal Asset Management Co., Ltd. | SHANGHAI, F4 | $132K | 3,600 |
| CITIGROUP INC | NEW YORK, NY | $77K | 2,095 |
| GSA CAPITAL PARTNERS LLP | LONDON, X0 | $649 | 17,661 |

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| [Fidelity Growth Company Fund](https://search.stillhousedata.com/fund/S000007119) | Fidelity Mt. Vernon Street Trust | $14.9M | 1.51% |
| [VANGUARD RUSSELL 2000 INDEX FUND](https://search.stillhousedata.com/fund/S000030003) | VANGUARD SCOTTSDALE FUNDS | $203K | 0.12% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/423494103.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.